Oligodendroglioma: pathology, molecular mechanisms and markers. Read more about Oligodendroglioma: pathology, molecular mechanisms and markers.
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Read more about Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment. Read more about Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Read more about High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN).
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Read more about A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas.
Germ-line and somatic DICER1 mutations in pineoblastoma. Read more about Germ-line and somatic DICER1 mutations in pineoblastoma.
Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Read more about Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Read more about CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Read more about Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Read more about Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.
